Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Edition
European
US
Dermatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Bimekizumab▼in Hidradenitis Suppurativa (HS)
14
Mins
January 2026
Experts explore 3-year clinical data on bimekizumab presented at the 2025 EADV and SHSA congresses, highlighting its durable and deep…
Read more
7
Mins
23 Nov 2023
Bimekizumab 3-Year Efficacy in Patients with Moderate-to-Severe Plaque Psoriasis: Response Maintenance, Re-treatment, and Effect on High-Impact Areas
Psoriasis symptoms can be not only uncomfortable, irritating, and painful, but can also impact several aspects of a patients’ daily life…
8
Mins
23 Nov 2023
Secukinumab for Patients with Moderate-to-Severe Hidradenitis Suppurativa: Post Hoc Analyses of Efficacy Endpoints, Draining Tunnels, Skin Pain, and Work Productivity
Due to the clinical heterogenicity of HS, assessment of disease severity is complex, and over 20 different outcome measures have…
2
Mins
23 Nov 2023
Efficacy and Safety of Upadacitinib in a Phase II Randomised, Double-Blind, Dose-Ranging Study of Adults with Extensive Non-segmental Vitiligo
Vitiligo is an autoimmune skin disorder that causes depigmentation of the skin and/or leukotrichia of the hair, resulting from the…
10
Mins
23 Nov 2023
A New Landmark for Wellbeing in Psoriasis: The POSITIVE Study
Psoriatic disease is a chronic, inflammatory immune condition affecting more than 40 million individuals worldwide…
13
Mins
17 Nov 2023
Platelet-Rich Plasma Applications, The Past 5 Years
This review article aims to provide an overview of platelet-rich plasma’s applications and evidence over the past 5 years in randomised…
9
Mins
26 Oct 2023
Editor's Pick: Diagnostic Evaluation of Hair Loss: A Narrative Review
This review provides a systematic approach for dermatologists to use in order to accurately diagnose hair loss disorders…
10
Mins
12 Oct 2023
Patient Centricity in Skin Treatments: Global Meeting of Experts in Dermatology
During this symposium, global experts in dermatology gave a series of lectures focused on skin treatments and their benefits for patients…
5
Mins
5 Oct 2023
Mycosis Fungoides Palmaris et Plantaris Progressing to Complete Early-Stage Disease Improved with Phototherapy
Mycosis fungoides is the most common form of cutaneous T cell lymphoma. In this article, the authors describe a case of a 53-year-old…
Loading posts...
« Previous
1
…
5
6
7
8
9
…
30
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View